Business
BUSINESS|BUSINESSFDA adds strongest warning to Sarepta gene therapy linked to 2 patient deathsThe Food and Drug Administration said Friday it will add a new warning and other limitations to a gene therapy for Duchenne’s muscular dystrophy that's been linked to two patient deaths. The infused therapy from Sarepta Therapeutics will carry a boxed warning — the most serious type — alerting doctors and patients to the risk of potentially fatal liver failure with the treatment, the FDA said in a release. The one-time therapy, Elevidys, has been under FDA scrutiny since the company reported t
BUSINESS|BUSINESSNew Cheetos and Doritos will be free of artificial dyesNew versions of Cheetos and Doritos, without artificial flavors or dyes, will be sold in December.
BUSINESS|BUSINESSDoritos and Cheetos debut 'NKD' options, without artificial colors or flavorsPepsiCo announced on Thursday that its Cheetos and Doritos brands will be offering "colorless" alternatives
BUSINESS|BUSINESSUS FDA approves Kura-Kyowa's blood cancer therapyBy Kamal Choudhury and Christy Santhosh (Reuters) -The U. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
BUSINESS|BUSINESSDoritos and Cheetos dial back the bright orange in new versions without artificial ingredientsDoritos and Cheetos are getting a makeover. PepsiCo said Thursday it’s launching toned-down versions of its bright orange snacks that won't have any artificial colors or flavors. Doritos and Cheetos Simply NKD will hit store shelves on Dec. 1.
BUSINESS|BUSINESSAmazon sued over 'punitive' handling of employee absencesBy Jonathan Stempel NEW YORK (Reuters) -Amazon.com was sued on Wednesday in a proposed class action saying the retailer subjects thousands of warehouse employees with disabilities to a "punitive"
BUSINESS|BUSINESSShah Capital pushes for Novavax sale, warns of proxy fightBy Sneha S K and Sriparna Roy (Reuters) -Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a potential sale, and warned it could launch a proxy fight if no progress is made in the next four months. In a second letter to Novavax's board in less than a month, shared exclusively with Reuters on Wednesday, Shah Capital said it has become "increasingly disenchanted" with the company's weak COVID-19 vaccine sales.
BUSINESS|BUSINESSTop German court to rule on claims by Wirecard shareholdersGermany's Federal Court of Justice (BGH) is set to rule on Thursday on claims by Wirecard shareholders in the insolvency of the former DAX company. The question at issue is whether aggrieved shareholders can claim damages from the insolvency estate as ordinary creditors or not.
BUSINESS|BUSINESSAmazon sued over 'punitive' handling of employee absencesBy Jonathan Stempel NEW YORK (Reuters) -Amazon.com was sued on Wednesday in a proposed class action saying the retailer subjects thousands of warehouse employees with disabilities to a "punitive"
LATEST POSTS
- 1
Why the chemtrail conspiracy theory lingers and grows – and why Tucker Carlson is talking about it - 2
Scientists document a death from a meat allergy tied to certain ticks - 3
Blue Origin’s New Glenn rocket landed its booster on a barge at sea – an achievement that will broaden the commercial spaceflight market - 4
Discovery of massive spider's web in Greece reveals unexpected behavior - 5
Explainer-What has happened to the damaged spacecraft at China's space station?












